| VERTEX PHARMACEUTICALS |
| USA |
| Gesundheit |
| US92532F1003 / 882807 |
| VX1 (Frankfurt) / VRTX (NASDAQ) |
| FRA:VX1, ETR:VX1, VX1:GR, NASDAQ:VRTX |
| https://www.vrtx.com/ |
|
Vertex Pharmaceuticals Incorporated Common Stock represents ownership in Vertex Pharmaceuticals Incorporated, a global biotechnology company focused on discovering, developing, manufacturing, and commercializing medicines for serious diseases. The co..
>Volltext.. |
| 126925.77 Mio. EUR |
| 121765.21 Mio. EUR |
| 11378.62 Mio. EUR |
| 4695.98 Mio. EUR |
| 3947.17 Mio. EUR |
| 15.52 EUR |
| 1771.98 Mio. EUR |
| 5514.23 Mio. EUR |
| 3846.55 Mio. EUR |
| 2 |
| 14.95% |
| 24.91% |
| - |
| - |
| - |
| - |
| VERTEX PHARMACEUTICALS, VERTEX PHARMA, VRTX |
| 01.11.26 |